BioLargo Inc. Reports Q2 2025 Financial Results
BioLargo, Inc., a company specializing in sustainable technologies and environmental engineering, has announced its Q2 2025 operating and financial results. The company, listed on the OTCQX under the ticker BLGO, reported revenues of $2.77 million for the second quarter and $6.04 million for the first half of 2025. This financial update was shared across multiple platforms, including feeds.feedburner.com, finanznachrichten.de, and stocktitan.net, on August 13, 2025.
A significant highlight from the report is the remarkable 517% increase in revenue within the engineering segment, specifically in air quality control services. This growth underscores BioLargo’s strong performance in addressing environmental challenges through innovative solutions.
In addition to financial achievements, BioLargo has made notable advancements in its technology sectors. Clyra Medical Technologies, a subsidiary of BioLargo, has secured distribution agreements covering 6,100 hospitals, marking a substantial expansion in its market reach.
BioLargo’s commitment to addressing environmental issues is evident in its diverse portfolio, which includes technologies for PFAS contamination, advanced water and wastewater treatment, industrial odor and VOC control, air quality, and infection control. The company’s efforts are supported by its extensive patent portfolio and validated products.
Looking ahead, BioLargo will host an investor webcast and conference call on August 15, 2025, at 11 AM Eastern Time. This event will provide further insights into the company’s financial performance, recent milestones, and future strategies. The webcast will be accessible to the public, offering an opportunity for investors and stakeholders to engage with the company’s leadership.
As of August 12, 2025, BioLargo’s stock closed at $0.18, with a 52-week range between $0.16 and $0.32. The company’s market capitalization stands at approximately $54.57 million, and it has a price-to-earnings ratio of -17.08, reflecting its current financial position.
BioLargo, Inc. continues to focus on developing and commercializing technologies that address critical environmental challenges, positioning itself as a leader in the cleantech and environmental solutions sectors. For more detailed information, stakeholders are encouraged to review the company’s SEC filings available on its website.